Table 2.
Treatment outcomes in TB patients enrolled for treatment in 18 health facilities in Nairobi, Kenya, during pre-COVID-19 and COVID-19 periods.
| Treatment Outcomes in Patients Enrolled for TB Treatment | Pre-COVID-19 Mar 2019–Feb 2020 n |
COVID-19 Mar 2020–Feb 2021 n |
Difference between Pre-COVID-19 and COVID-19 % |
|---|---|---|---|
| Enrolled for treatment: | 3640 | 2366 | |
| Treatment Success (%) | (65.0) | (67.0) | ↑2.0 * |
| Loss to Follow-up (%) | (7.3) | (7.0) | ↓0.3 * |
| Died (%) | (4.2) | (5.0) | ↑0.8 * |
| Failed treatment (%) | (0.8) | (0.5) | ↓0.3 * |
| Not evaluated (%) | (22.7) | (20.5) | ↓2.2 * |
* absolute change (increase or decrease); TB = tuberculosis; treatment outcome was considered “treatment success” when the TB patient was either cured or had “treatment completed”. The success rate was calculated for the month-wise cohort of TB patients commenced on treatment eight months before the reporting month (considering six months of treatment to be completed and another two months to finalize the recording of outcomes).